abstract |
The present invention relates to compositions and methods for treating hepatitis B virus infection. In particular, the invention relates to a combination therapy comprising administration of a TLR7 agonist and an HBV capsid assembly inhibitor for treating a patient with chronic hepatitis B infection. |